F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control

Metabolism: Clinical and Experimental
Lilliam FloresE Esmatjes

Abstract

Much evidence has suggested that oxidative stress (OS) may play a role in the pathogenesis of diabetic complications. However, the relationship between hyperglycemia and OS is inconsistent in diabetic clinical studies. The aim of this study was to evaluate the effect of normalization of blood glucose levels on urinary 8-epi-prostaglandin F(2alpha) (8-epi-PGF(2alpha)) excretion at the onset of type 1 diabetes. We studied 14 type 1 diabetic patients (50% males; mean age, 24.3 +/- 4.9 years) and 14 control subjects matched by age and body mass index. A 24-hour urine collection was performed to determine 8-epi-PGF(2alpha) as an integrated index of OS production at baseline, before starting insulin therapy, and 16 weeks later. Insulin treatment induced a significant reduction in glycosylated hemoglobin (HbA(1c)) (from 11.5% to 5.4% P =.0001), triglycerides (from 1.0 to 0.8 mmol/L, P =.002), and an increase in high-density lipoprotein (HDL)-cholesterol levels (from 1.1 to 1.5 nmol/L, P =.01) at week 16. This improvement in metabolic control was associated with a statistically significant reduction in 8-epi-PGF(2alpha) values (from 92.0 +/- 41.5 to 66.9 +/- 28.9 pg/mg urinary reatinine excretion, P =.015), although compared with the c...Continue Reading

References

Jul 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·A CerielloP J Lefèbvre
Mar 1, 1995·Diabetes Research and Clinical Practice·B Wierusz-WysockaM Kaźmierczak
Feb 17, 1996·Lancet·P DandonaT Nicotera
Apr 28, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·I C West

❮ Previous
Next ❯

Citations

Jul 24, 2010·Journal of Physiology and Biochemistry·María Isabel Burgos AlvesSoledad Parra Pallarés
Aug 4, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Hui YangSheng-Kai Yan
Jun 16, 2005·Current Opinion in Cardiology·Theodore Mazzone
Nov 15, 2011·Experimental and Molecular Pathology·William H HoffmanAnuska V Andjelkovic
Mar 19, 2011·Toxicology·Klaudia Jomova, Marian Valko
Mar 12, 2010·Diabetes/metabolism Research and Reviews·Agnès MathesonBradley J Walsh
May 4, 2005·The Journal of Nutritional Biochemistry·Janet Y Uriu-AdamsCarl L Keen
Aug 23, 2005·Molecular Aspects of Medicine·Janet Y Uriu-Adams, Carl L Keen
Dec 4, 2010·Free Radical Biology & Medicine·Sean S Davies, L Jackson Roberts
Apr 26, 2007·Journal of Lipid Research·Weiying YanMichael W Ogden
Nov 11, 2017·The Journal of Clinical Endocrinology and Metabolism·Eugene J BarrettCarolina M Casellini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.